Cancer incidence after nasopharyngeal radium irradiation.
BACKGROUND
From 1940 until 1970, nasopharyngeal radium irradiation was used to treat children and military personnel suffering from Eustachian tube failure attributable to local lymphoid hyperplasia.


METHODS
We studied cancer incidence in a cohort of 4339 Dutch patients treated with nasopharyngeal radium irradiation, mostly in childhood, and 4104 frequency-matched nonexposed subjects. Average doses to the nasopharynx, pituitary gland, brain, and thyroid gland were 275, 10.9, 1.8, and 1.5 cGy, respectively. We assessed cancer incidence from cancer registry linkage (1989-1996), self-report including medical verification (1945-1988), and death certificates (1945-1996).


RESULTS
During 18-50 years of follow-up, four thyroid malignancies (standardized incidence ratio [SIR] = 2.8; 95% confidence interval [CI] = 0.8-7.2) and five malignant brain tumors (SIR = 1.3; CI = 0.4-3.1) were observed. Increased risks were observed for malignancies of lymphoproliferative and hematopoietic origin (SIR = 1.9; CI = 1.2-2.8) and breast cancer (SIR = 1.5; CI = 1.1-2.1). Strong dose-response trends could not be demonstrated for any cancer outcome, although relative risk estimates were elevated in the highest-dose category for head and neck cancer and breast cancer.


CONCLUSIONS
These data provide little evidence for a high excess risk of cancer associated with nasopharyngeal radium irradiation treatment as applied in the Netherlands. Inconsistent findings across studies and public concern warrant the continuing follow-up of available cohorts.
Ronckers
Cécile M
CM
Department of Ear-Nose and Throat Medicine, Reinaert Kliniek, Maastricht, the Netherlands. ronckerc@mail.nih.gov
Van Leeuwen
Flora E
FE
Hayes
Richard B
RB
Verduijn
Pieter G
PG
Stovall
Marilyn
M
Land
Charles E
CE
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000453:epidemiology / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D008221:Lymphoid Tissue / Q000528:radiation effects; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009305:Nasopharynx / Q000528:radiation effects*; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology* / Q000209:etiology; D009426:Netherlands / Q000453:epidemiology; D010038:Otorhinolaryngologic Diseases / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011883:Radium / Q000627:therapeutic use*
D011883:Radium